|
PDCD6IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.90330000000061E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.54810000000594E-05 |
| Normal-vs-Stage2 |
2.588300E-02 |
| Normal-vs-Stage3 |
1.755440E-04 |
| Normal-vs-Stage4 |
7.03739999607933E-09 |
| Stage1-vs-Stage2 |
8.535200E-01 |
| Stage1-vs-Stage3 |
1.583600E-01 |
| Stage1-vs-Stage4 |
1.819890E-03 |
| Stage2-vs-Stage3 |
3.748000E-01 |
| Stage2-vs-Stage4 |
4.636100E-02 |
| Stage3-vs-Stage4 |
2.040800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98070000001493E-06 |
| Normal-vs-AfricanAmerican |
7.81619999999927E-05 |
| Normal-vs-Asian |
6.507900E-02 |
| Caucasian-vs-AfricanAmerican |
6.304200E-01 |
| Caucasian-vs-Asian |
5.511000E-01 |
| AfricanAmerican-vs-Asian |
6.396200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38500000357311E-08 |
| Normal-vs-Female |
1.877770E-01 |
| Male-vs-Female |
8.064100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.48589999999327E-05 |
| Normal-vs-Extreme_Weight |
2.52779999998509E-06 |
| Normal-vs-Obese |
2.617800E-04 |
| Normal-vs-Extreme_Obese |
1.130380E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.040000E-01 |
| Normal_Weight-vs-Obese |
3.340600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.158400E-01 |
| Extreme_Weight-vs-Obese |
4.380800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.355400E-01 |
| Obese-vs-Extreme_Obese |
9.624000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.063900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.418700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.60490000014713E-07 |
| Normal-vs-Age(81-100Yrs) |
8.735000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.932200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.405800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.373800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.833620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.065400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.280400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01779999999818E-05 |
| Normal-VS-Type2 PRCC |
5.19570000023784E-07 |
| Normal-VS-KIRP CIMP |
1.342040E-02 |
| Normal-VS-Unclassified PRCC |
2.053400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.325500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.584000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.034000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.778200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.335500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.731600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.07390000015207E-08 |
| Normal-vs-N1 |
2.35579999999791E-05 |
| Normal-vs-N2 |
2.34000000000067E-05 |
| N0-vs-N1 |
8.068400E-01 |
| N0-vs-N2 |
4.133800E-01 |
| N1-vs-N2 |
2.936800E-01 |
|
|
